Filtered By:
Cancer: Cancer

This page shows you your search results in order of relevance. This is page number 19.

Order by Relevance | Date

Total 150053 results found since Jan 2013.

The IAEA Technical Cooperation Programme and Nuclear Medicine in the Developing World: Objectives, Trends, and Contributions
The International Atomic Energy Agency's technical cooperation (TC) programme helps Member States in the developing world with limited infrastructure and human resource capacity to harness the potential of nuclear technologies in meeting socioeconomic development challenges. As a part of its human health TC initiatives, the Agency, through the TC mechanism, has the unique role of promoting nuclear medicine applications of fellowships, scientific visits, and training courses, via technology procurement, and in the past decade has contributed nearly $54 million through 180 projects in supporting technology procurement and hu...
Source: Seminars in Nuclear Medicine - April 14, 2013 Category: Radiology Authors: Juan Antonio Casas-Zamora, Ridhi Kashyap Source Type: research

Interview: The commercialization of regenerative medicine into a routine healthcare offering.
Abstract Robert Deans speaks to Alexandra Hemsley, Commissioning Editor Robert Deans has led Athersys Inc.'s (OH, USA) regenerative medicine research and development activities since February 2003 and has served as Vice President of Regenerative Medicine since October 2003. He was named Executive Vice President of Regenerative Medicine in April 2011. Deans is highly regarded as an expert in stem cell therapeutics, with over 20 years of experience in this field. From 2001 to 2003, Deans worked for early-stage biotechnology companies. Deans was formerly the Vice President of Research at Osiris Therapeutics, Inc. (MD...
Source: Regenerative Medicine - May 1, 2013 Category: Genetics & Stem Cells Authors: Deans R Tags: Regen Med Source Type: research

Genomic medicine in primary care: barriers and assets
Sequencing the human genome created the tantalising promise of more personalised medicine. Futurists envisage a time when each individual undergoes genome sequencing at birth, stores the data on a chip or in an electronic health record (EHR), and allows healthcare providers to query it throughout one's life. Genomic medicine, the use of one's genotype in medical decision-making, may improve health outcomes, but the clinical translation of this vast body of scientific information is in its infancy. Nonetheless, some patients are eager to use genomic information to shape their healthcare now. Primary care providers (PCPs), h...
Source: Postgraduate Medical Journal - October 15, 2013 Category: Journals (General) Authors: Vassy, J. L., Green, R. C., Lehmann, L. S. Tags: General practice / family medicine, Drugs: cardiovascular system, Stroke, Gynecological cancer, Guidelines Editorials Source Type: research

Translational Research of Optical Molecular Imaging for Personalized Medicine.
Abstract In the medical imaging field, molecular imaging is a rapidly developing discipline and forms many imaging modalities, providing us effective tools to visualize, characterize, and measure molecular and cellular mechanisms in complex biological processes of living organisms, which can deepen our understanding of biology and accelerate preclinical research including cancer study and medicine discovery. Among many molecular imaging modalities, although the penetration depth of optical imaging and the approved optical probes used for clinics are limited, it has evolved considerably and has seen spectacular adv...
Source: Current Molecular Medicine - November 11, 2013 Category: Molecular Biology Authors: Qin C, Ma X, Tian J Tags: Curr Mol Med Source Type: research

How cancer patients build trust in traditional Chinese medicine
Conclusions: Knowing how advanced stage cancer patients build trust in TCM can increase understanding of their medical care-seeking behavior in TCM. These results may be helpful for clinicians in Asian countries where TCM is used along with conventional medicine and in countries treating Asian cancer patients.
Source: European Journal of Integrative Medicine - September 20, 2013 Category: Complementary Medicine Authors: Chun-Hao Liu, Woung-Ru Tang, Hung-Ming Wang, Ko-Chen Lee Tags: Original Articles Source Type: research

117in * should personalised medicine be funded in countries with limited resources?
Personalised medicine implies that treatment is based on molecular analysis of an individual tumour specimen. A biomarker may define groups of patients who can benefit from a specific treatment, such as the Estrogen Receptor and HER2 in breast cancer, B-RAF mutation in melanoma and EGFR and ALK mutation in lung cancer. Large clinical trials support treatments based on these tests but whether they should be used in countries of limited resources depends on their cost-effectiveness compared to other potential use of limited resources for health-care. ER and tamoxifen and HER2 and trastuzumab as adjuvant therapy for breast ca...
Source: Annals of Oncology - September 24, 2014 Category: Cancer & Oncology Authors: Tannock, I. F. Tags: ESMO Emerging Countries Committee (ECC) - AORTIC-SLACOM-UICC joint symposium: personalised medicine with limited resources: myth or reality? Source Type: research

Three advantages of using traditional Chinese medicine to prevent and treat tumor
Publication date: July 2014 Source:Journal of Integrative Medicine, Volume 12, Issue 4 Author(s): Chang-quan Ling , Xiao-qiang Yue , Chen Ling Traditional Chinese medicine (TCM), an important component of complementary and alternative medicine, has evolved over thousands of years with its own unique system of theories, diagnostics and therapies. TCM has been increasingly used in the last decades and become well known for its significant role in preventing and treating cancer. We believe that TCM possesses advantages over Western medicine in specific aspects at a certain stage of cancer treatment. Here we summarize the ad...
Source: Journal of Integrative Medicine - November 3, 2014 Category: Complementary Medicine Source Type: research

Personalized medicine-based strategy for prostate cancer
Publication date: July 2014 Source:Personalized Medicine Universe, Volume 3 Author(s): Akinobu Gotoh With the emergence of molecularly targeted drugs, the phrase “personalized medicine” has recently become frequently used in the medical community. This phrase basically refers to treatments based on the selection of optimum therapies for individual patients but it can also include treatments based on the integration of various new technologies to enhance clinical care. Interest in personalized medicine will likely continue to increase in the future. Given the rapid advances in molecular biology, genetic engineering, b...
Source: Personalized Medicine Universe - November 6, 2014 Category: Drugs & Pharmacology Source Type: research

The ethics of personalized medicine
Publication date: July 2014 Source:Personalized Medicine Universe, Volume 3 Author(s): Jack Kushner Personalized medicine is that branch of medicine whereby a patient's treatment and prognosis are based on his genes. Recent genetic research explains the variations and similarities between humans, their diseases, and their responses to various treatments. Because governments and universities have not set strict standards, there are numerous tests and kits available to detect genetic problems. But are these kits accurate? The validity of some biomarkers is suspect. The ethics of personalized medicine became an issue when s...
Source: Personalized Medicine Universe - November 6, 2014 Category: Drugs & Pharmacology Source Type: research

Application of Response Evaluation Criteria of Traditional Chinese Medicine for Solid Tumor in advanced non-small cell lung cancer
Conclusions REC-TCM-ST was used to evaluate the therapeutic effect of CM in the treatment of advanced NSCLC, which shows that its evaluation results can better reflect the advantages and disadvantages of CM, and the effectiveness of CM is more objective and comprehensive than RECIST, so REC-TCM-ST is worthy of further improvement and clinical expansion.
Source: Chinese Journal of Integrative Medicine - November 26, 2014 Category: Internal Medicine Source Type: research

Abstract SS03-01: Promise and pitfalls of personalized medicine from a clinical science perspective
Personalized medicine tailors treatment to meet an individual patient's needs and specific disease. While the idea of personalized medicine is not new, advances in biomedical science have evolved to target molecular pathways to reduce toxicity and provide more effective treatment options to patients with many common cancers. For a few cancers, such as breast cancer, biomarker assisted diagnoses and therapy have already replaced the standard "one size fits all" treatment. As our understanding of molecular genetics increases we will be able to offer tailored cancer therapy to more patients, however, the cost of cancer care w...
Source: Cancer Epidemiology Biomarkers and Prevention - November 13, 2014 Category: Cancer & Oncology Authors: duPont, N. C. Tags: Precision/ Personalized Medicine: Oral Presentations - Invited Abstracts Source Type: research

How digital health tools figure into the White House’s Precision Medicine initiative
Last week the White House provided more details about the new $215 million Precision Medicine program that President Obama briefly mentioned during his State of the Union address. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes — and to give all of us access […]
Source: mobihealthnews - February 2, 2015 Category: Information Technology Authors: Brian Dolan Tags: Uncategorized Google Baseline Google Biogen New England Journal Medicine Precision Medicine Initiative SOTU State of the Union Address White House Precision Medicine Source Type: news

Complementary Medicine for Cancer Patients in General Practice: Qualitative Interviews with German General Practitioners
Conclusion: Although general practitioners see themselves as an important source of information on complementary medicine for their cancer patients, they also speak of their uncertainties and lack of knowledge. General practitioners would profit from training in complementary medicine enabling them to discuss this topic with their cancer patients in a proactive, open and honest manner.Forsch Komplementmed
Source: Research in Complementary Medicine - February 4, 2015 Category: Complementary Medicine Source Type: research

Effects of oriental medicine music therapy in an ovarian cancer patient with So-Eum-type constitution: a case report
Publication date: Available online 31 December 2014 Source:Integrative Medicine Research Author(s): Seung-Hyun Lee , Eunhye Song , Seul-Ki Kim The cancer incidence in Korea has been increasing, although there is a serious lack of supportive care for the treatment and management of the rapidly increasing number of cancer patients, and there is an immense need for therapeutic interventions to support cancer patients. A 47-year-old So-Eum-type Korean female patient, who was diagnosed with ovarian cancer, had been receiving chemotherapies. She was experiencing pain due to swelling of her hands and feet, and under extreme str...
Source: Integrative Medicine Research - February 16, 2015 Category: Complementary Medicine Source Type: research

Mind the Gap! Lay and Medical Perceptions of Risks Associated with the Use of Alternative Treatment and Conventional Medicine
Conclusion: For the safety of CAM users, such divergent risk perceptions may have far-reaching consequences. CAM users should be taken seriously with their self-perception as decision-makers considering their approaches to experiences, knowledge, and science. An awareness of differing lay and medical risk perceptions associated with CAM and conventional medicine in research, doctor-patient communication, and education of patients and doctors is thus important to optimize patient safety in complex health care systems.Forsch Komplementmed
Source: Research in Complementary Medicine - February 18, 2015 Category: Complementary Medicine Source Type: research